BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22475920)

  • 1. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
    Sheth S; Colletti PM
    Clin Nucl Med; 2012 May; 37(5):e110-6. PubMed ID: 22475920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
    Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
    Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
    Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
    BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    Wong KK; Piert M
    J Nucl Med; 2013 Apr; 54(4):590-9. PubMed ID: 23482667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
    Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
    Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases.
    Li Y; Schiepers C; Lake R; Dadparvar S; Berenji GR
    Bone; 2012 Jan; 50(1):128-39. PubMed ID: 22001678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    Freesmeyer M
    J Nucl Med; 2013 Dec; 54(12):2190. PubMed ID: 24198385
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply: Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    Wong KK; Piert M
    J Nucl Med; 2013 Dec; 54(12):2190-1. PubMed ID: 24198387
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ahuja K; Sotoudeh H; Galgano SJ; Singh R; Gupta N; Gaddamanugu S; Choudhary G
    J Nucl Med Technol; 2020 Mar; 48(1):9-16. PubMed ID: 31811067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal PET with 18F-fluoride: applying new technology to an old tracer.
    Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST
    J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier detection of bone metastases from pleomorphic liposarcoma in a pediatric patient by FDG PET/CT than planar 99mTc MDP bone scan.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Clin Nucl Med; 2012 May; 37(5):e104-7. PubMed ID: 22475918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Langsteger W; Rezaee A; Pirich C; Beheshti M
    Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
    [No Abstract]   [Full Text] [Related]  

  • 18. Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report.
    Chan HP; Hu C; Yu CC; Huang TC; Peng NJ
    Medicine (Baltimore); 2015 Apr; 94(13):e687. PubMed ID: 25837761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative
    Coskun N; Cagdas B; Yildirim N
    Hell J Nucl Med; 2022; 25(2):132-137. PubMed ID: 35913859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.